Jakarta, February 2 2024
Deputy Minister of Health of the Republic of Indonesia Prof. Dr. Dante Saksono Harbuwono said one way to overcome the problem of cervical cancer in Indonesia is by screening as early as possible.
“One of the highest causes of cancer death for women in Indonesia is cervical cancer. “Cervical cancer screening is one of the main modalities to overcome the high cervical cancer mortality rate in Indonesia,” said Prof. Dante in a discussion about cervical cancer, Friday (2/2) in Jakarta
Cervical cancer is the second most common cancer in women in Indonesia. However, 70% of women diagnosed with cervical cancer have entered an advanced stage. In fact, treatment at this stage becomes less effective. As a result, 50% of women diagnosed with cervical cancer die from the disease.
The government through the Ministry of Health has implemented a number of strategies to overcome the problem of cervical cancer in Indonesia, including HPV vaccination for school-aged girls and conducting cervical cancer detection screening as early as possible for Indonesian women. In fact, the government has carried out a pilot project for free HPV vaccination in schools in Jakarta. The government has also provided adequate treatment for cervical cancer in Indonesia.
Furthermore, the Ministry of Health developed a National Action Plan (RAN) for Cervical Cancer Eradication for Indonesia (2023-2030). The future vision of this action plan is to make cervical cancer a disease of the past, and every woman in all socio-economic demographics can live healthy and free from the threat of cervical cancer.
The priority in the national action plan is cervical cancer screening, with a target of screening 75% of all women aged 30-69 years. This screening uses an HPV DNA examination method which has guaranteed quality.
One important part of this national action plan is the transition of primary cervical cancer screening methods from the current method to HPV DNA screening. In 2020, cervical cancer screening via the acetic acid visual inspection (IVA) method and cytology examination only covered 9.3% of women in the target population, with significant variations between provinces.
The HPV DNA screening method is carried out with appropriate clinical guidelines and protocols, including transportation for centralized testing, as well as strengthening laboratory capabilities.
The Ministry of Health is also considering alternative screening strategies such as screening at healthcare settings and self-sampling methods.
To achieve screening targets in an effort to eliminate cervical cancer, it is important for Indonesia to implement efficient screening methods, tools and technology. To achieve this goal, the NAP calls for a review of international scientific evidence and best practices.
This news was broadcast by the Communications and Public Services Bureau, Indonesian Ministry of Health. For further information, please contact the Halo Ministry of Health hotline number via hotline number 1500-567, SMS 081281562620 and email address [email protected].
Head of the Communications and Public Services Bureau
Dr. Siti Nadia Tarmizi, M. Epid
2024-02-02 14:11:32
#Cervical #Cancer #Screening #Main #Capital #Address #Womens #Deaths
